NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

動物用醫藥品的全球市場:各產品類型,動物類型,給藥途徑,感染類型,終端用戶,流通管道,地區,企業,預測和機會(2026年)

Global Animal Pharmaceuticals Market, By Product Type, By Animal Type, By Route of Administration, By Type of Infection, By End User, By Distribution Channel, By Region, By Company, Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 1008722
出版日期 內容資訊 英文 114 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

動物用醫藥品的全球市場:各產品類型,動物類型,給藥途徑,感染類型,終端用戶,流通管道,地區,企業,預測和機會(2026年) Global Animal Pharmaceuticals Market, By Product Type, By Animal Type, By Route of Administration, By Type of Infection, By End User, By Distribution Channel, By Region, By Company, Forecast & Opportunities, 2026
出版日期: 2021年06月01日內容資訊: 英文 114 Pages
簡介

動物用醫藥品市場,2020年是452億3,000萬美金。

該市場,在預測期間預計以7.05%穩定的年複合成長率成長,2026年達到684億5,000萬美元。這個成長,起因於寵物飼養增加,牛奶的整體消費量增加,伊波拉出血熱和豬流感等致命疾病從動物擴大。

動物用醫藥品,對動物的疾病診斷和治療非常有效。由於新經濟的出現,政府和製藥公司提供動物醫療資金,因此導致市場擴大。抑制市場的要素,是動物實驗相關政府的規則,及電子商務平台的假醫藥品銷售的可能性等。

本報告提供全球動物用醫藥品市場的相關調查,市場規模和預測,佔有率,COVID-19的影響,成長要素和課題,各產品類型、動物類型、給藥途徑、感染類型、終端用戶、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球動物用醫藥品市場的影響

第4章 摘要整理

第5章 客戶的迴響

  • 全球動物用醫藥品市場成長的促進因素
  • 購買決策的影響因素
  • 品牌認知度

第6章 全球動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型(醫藥品,疫苗,藥用飼料)
    • 各動物類型(寵物,家畜)
    • 各給藥途徑(口服,非口服,局部)
    • 各感染類型(病毒,細菌,寄生蟲,其他)
    • 各終端用戶(動物醫院,動物診所,照護現場/院內檢驗,其他)
    • 各流通管道(動物醫院,藥局,藥妝店,電子商務)
    • 各企業(2020)
    • 各地區
  • 產品市場地圖

第7章 北美的動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型
    • 各動物類型
    • 各給藥途徑
    • 各感染類型
    • 各終端用戶
    • 各流通管道
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第8章 歐洲的動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型
    • 各動物類型
    • 各給藥途徑
    • 各感染類型
    • 各終端用戶
    • 各流通管道
    • 各國
  • 歐洲:各國分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第9章 亞太地區的動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型
    • 各動物類型
    • 各給藥途徑
    • 各感染類型
    • 各終端用戶
    • 各流通管道
    • 各國
  • 亞太地區:各國分析
    • 澳洲
    • 日本
    • 中國
    • 印度
    • 韓國

第10章 南美的動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型
    • 各動物類型
    • 各給藥途徑
    • 各感染類型
    • 各終端用戶
    • 各流通管道
    • 各國
  • 南美:各國分析
    • 阿根廷
    • 巴西
    • 哥倫比亞

第11章 中東及非洲的動物用醫藥品市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品類型
    • 各動物類型
    • 各給藥途徑
    • 各感染類型
    • 各終端用戶
    • 各流通管道
    • 各國
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭預測
  • 企業簡介(主要企業)
    • Zoetis Inc
    • Merck & Company Inc.
    • Boehringer Ingelheim GmbH
    • Elanco Animal Health Inc.
    • Vetoquinol SA
    • Virbac SA
    • Phibro Animal Health Corporation
    • Ceva Sante Animale S.A
    • Covetrus Inc.
    • Biogenesis Bago SA
    • Neogen Corporation Ltd.
    • Dechra Pharmaceuticals PLC
    • ImmuCell Corporation
    • Krka, tovarna zdravil, d. d., Novo mesto
    • ECO Animal Health Ltd.

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 4543

The animal pharmaceuticals market was valued USD45.23 billion in 2020 and is likely to grow with a steady CAGR of 7.05% in the forecast period to reach USD68.45 billion by 2026 due to the increase in pet adoption, rise in overall consumption of milk and meat, and fatal diseases like Ebola and swine flu spreading from animals. Animal pharmaceuticals are highly beneficial in the diagnosis and treatment of animal disorders. The emergence of new economies has led more governments and pharma companies to fund animal healthcare, consequently pushing the market forward. The restraining factors for the market can be the government rules regarding animal testing, and the probability of the sales of fake medicines across e-commerce platforms.

The global animal pharmaceuticals market is segmented based on product type, animal type, route of administration, type of infection, end user, distribution channel and region. Based on product type, the market is segmented into drugs, vaccines and medicated feed. The drugs segment dominates the market due to the rise in diseases and various infections. On the basis of animal type, the market is segmented into companion and livestock animals. Companion animals tend to hold a larger share in the market as pet owners ensure their pet's health and well-being. As compared to livestock animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment. Based on route of administration, the pharmaceutical products, i.e., drugs and medicated feed are given orally hence the oral route of administration dominates the market. Viral infections dominate the type of infection segment pertaining to their ease of spread and rate of infection. Veterinary clinics are expected to grow at a faster rate because they provide specialized pet/ livestock treatment however, veterinary hospitals are still likely to dominate the end user segment. Based on distribution channel, e-commerce segment is expected to grow at a faster rate in the future because of continuous technological advancements that make it the most convenient option for pet and livestock owners.

The overall animal pharmaceuticals market is widespread, expanding itself to various regions including Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America has the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, the fastest growth is shown by the Asia-Pacific region due to the prevalence of animal-borne diseases like swine flu and Ebola.

The top leading players of the animal pharmaceuticals market are Zoetis Inc, Merck and Company, Vetoquinol SA, Virbac SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Phibro Animal Health Corporation, Biogenesis Bago SA, Neogen Corporation Ltd., Dechra Pharmaceuticals PLC, ImmuCell Corporation, Krka, tovarna zdravil, d. d., Novo mesto, and ECO Animal Health Ltd., etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing the animal healthcare sector.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026F

Objective of the Study:

  • To analyze the historical growth in the market size of the global animal pharmaceuticals market from 2016 to 2020.
  • To estimate and forecast the market size of the global animal pharmaceuticals market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the global animal pharmaceuticals market based on product type, animal type, route of administration, type of infection, end user, distribution channel and region.
  • To identify drivers and challenges for the global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global animal pharmaceuticals market.
  • To conduct pricing analysis for the global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in the global animal pharmaceuticals market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research was able to include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of the global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Animal healthcare centers, vets
  • Research organizations and consulting companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, the global animal pharmaceuticals market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Animal Pharmaceuticals Market, By Product Type:

Drugs

Vaccines

Medicated Feed

  • Global Animal Pharmaceuticals Market, By Animal Type:

Companion Animal

Livestock Animal

  • Global Animal Pharmaceuticals Market, By Route of Administration:

Oral

Parenteral

Topical

  • Global Animal Pharmaceuticals Market, By Type of Infection:

Viral

Bacterial

Parasitic

Others

  • Global Animal Pharmaceuticals Market, By End User:

Veterinary Hospitals

Veterinary Clinics

Point of Care/ In-house Testing

Others

  • Global Animal Pharmaceuticals Market, By Distribution Channel:

Veterinary Hospitals

Pharmacies and Drug stores

E-commerce

  • Global Animal Pharmaceuticals Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

Asia-Pacific

  • Australia
  • Japan
  • China
  • India
  • South Korea

South America

  • Argentina
  • Brazil
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global animal pharmaceuticals market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Animal Pharmaceuticals Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Factors Driving the Growth of Global Animal Pharmaceuticals Market
  • 5.2. Factors Influencing Purchase Decision
  • 5.3. Brand Awareness

6. Global Animal Pharmaceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Drugs, Vaccines, Medicated Feed)
    • 6.2.2. By Animal Type (Companion animal, Livestock animal)
    • 6.2.3. By Route of Administration (Oral, Parenteral, Topical)
    • 6.2.4. By Type of Infection (Viral, Bacterial, Parasitic, Others)
    • 6.2.5. By End User (Veterinary Hospitals, Veterinary Clinics, Point of care/In-house testing, Others)
    • 6.2.6. By Distribution Channel (Veterinary Hospitals, Pharmacies and Drug stores, E-commerce)
    • 6.2.7. By Company (2020)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. North America Animal Pharmaceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Animal Type
    • 7.2.3. By Route of Administration
    • 7.2.4. By Type of Infection
    • 7.2.5. By End User
    • 7.2.6. By Distribution Channel
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Animal Pharmaceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Animal Type
        • 7.3.1.2.3. By Route of Administration
        • 7.3.1.2.4. By Type of Infection
        • 7.3.1.2.5. By End User
        • 7.3.1.2.6. By Distribution Channel
    • 7.3.2. Canada Animal Pharmaceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Animal Type
        • 7.3.2.2.3. By Route of Administration
        • 7.3.2.2.4. By Type of Infection
        • 7.3.2.2.5. By End User
        • 7.3.2.2.6. By Distribution Channel
    • 7.3.3. Mexico Animal Pharmaceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Animal Type
        • 7.3.3.2.3. By Route of Administration
        • 7.3.3.2.4. By Type of Infection
        • 7.3.3.2.5. By End User
        • 7.3.3.2.6. By Distribution Channel

8. Europe Animal Pharmaceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Animal Type
    • 8.2.3. By Route of Administration
    • 8.2.4. By Type of Infection
    • 8.2.5. By End User
    • 8.2.6. By Distribution Channel
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Animal Pharmaceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Animal Type
        • 8.3.1.2.3. By Route of Administration
        • 8.3.1.2.4. By Type of Infection
        • 8.3.1.2.5. By End User
        • 8.3.1.2.6. By Distribution Channel
    • 8.3.2. United Kingdom Animal Pharmaceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Animal Type
        • 8.3.2.2.3. By Route of Administration
        • 8.3.2.2.4. By Type of Infection
        • 8.3.2.2.5. By End User
        • 8.3.2.2.6. By Distribution Channel
    • 8.3.3. France Animal Pharmaceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Animal Type
        • 8.3.3.2.3. By Route of Administration
        • 8.3.3.2.4. By Type of Infection
        • 8.3.3.2.5. By End User
        • 8.3.3.2.6. By Distribution Channel
    • 8.3.4. Italy Animal Pharmaceuticals Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Animal Type
        • 8.3.4.2.3. By Route of Administration
        • 8.3.4.2.4. By Type of Infection
        • 8.3.4.2.5. By End User
        • 8.3.4.2.6. By Distribution Channel
    • 8.3.5. Spain Animal Pharmaceuticals Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Animal Type
        • 8.3.5.2.3. By Route of Administration
        • 8.3.5.2.4. By Type of Infection
        • 8.3.5.2.5. By End User
        • 8.3.5.2.6. By Distribution Channel

9. Asia-Pacific Animal Pharmaceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Animal Type
    • 9.2.3. By Route of Administration
    • 9.2.4. By Type of Infection
    • 9.2.5. By End User
    • 9.2.6. By Distribution Channel
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. Australia Animal Pharmaceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Animal Type
        • 9.3.1.2.3. By Route of Administration
        • 9.3.1.2.4. By Type of Infection
        • 9.3.1.2.5. By End User
        • 9.3.1.2.6. By Distribution Channel
    • 9.3.2. Japan Animal Pharmaceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Animal Type
        • 9.3.2.2.3. By Route of Administration
        • 9.3.2.2.4. By Type of Infection
        • 9.3.2.2.5. By End User
        • 9.3.2.2.6. By Distribution Channel
    • 9.3.3. China Animal Pharmaceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Animal Type
        • 9.3.3.2.3. By Route of Administration
        • 9.3.3.2.4. By Type of Infection
        • 9.3.3.2.5. By End User
        • 9.3.3.2.6. By Distribution Channel
    • 9.3.4. India Animal Pharmaceuticals Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By Animal Type
        • 9.3.4.2.3. By Route of Administration
        • 9.3.4.2.4. By Type of Infection
        • 9.3.4.2.5. By End User
        • 9.3.4.2.6. By Distribution Channel
    • 9.3.5. South Korea Animal Pharmaceuticals Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product Type
        • 9.3.5.2.2. By Animal Type
        • 9.3.5.2.3. By Route of Administration
        • 9.3.5.2.4. By Type of Infection
        • 9.3.5.2.5. By End User
        • 9.3.5.2.6. By Distribution Channel

10. South America Animal Pharmaceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Animal Type
    • 10.2.3. By Route of Administration
    • 10.2.4. By Type of Infection
    • 10.2.5. By End User
    • 10.2.6. By Distribution Channel
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Argentina Animal Pharmaceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Animal Type
        • 10.3.1.2.3. By Route of Administration
        • 10.3.1.2.4. By Type of Infection
        • 10.3.1.2.5. By End User
        • 10.3.1.2.6. By Distribution Channel
    • 10.3.2. Brazil Animal Pharmaceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Animal Type
        • 10.3.2.2.3. By Route of Administration
        • 10.3.2.2.4. By Type of Infection
        • 10.3.2.2.5. By End User
        • 10.3.2.2.6. By Distribution Channel
    • 10.3.3. Colombia Animal Pharmaceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Animal Type
        • 10.3.3.2.3. By Route of Administration
        • 10.3.3.2.4. By Type of Infection
        • 10.3.3.2.5. By End User
        • 10.3.3.2.6. By Distribution Channel

11. Middle East and Africa Animal Pharmaceuticals Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Animal Type
    • 11.2.3. By Route of Administration
    • 11.2.4. By Type of Infection
    • 11.2.5. By End User
    • 11.2.6. By Distribution Channel
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Animal Pharmaceuticals Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Animal Type
        • 11.3.1.2.3. By Route of Administration
        • 11.3.1.2.4. By Type of Infection
        • 11.3.1.2.5. By End User
        • 11.3.1.2.6. By Distribution Channel
    • 11.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Animal Type
        • 11.3.2.2.3. By Route of Administration
        • 11.3.2.2.4. By Type of Infection
        • 11.3.2.2.5. By End User
        • 11.3.2.2.6. By Distribution Channel
    • 11.3.3. UAE Animal Pharmaceuticals Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Animal Type
        • 11.3.3.2.3. By Route of Administration
        • 11.3.3.2.4. By Type of Infection
        • 11.3.3.2.5. By End User
        • 11.3.3.2.6. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Zoetis Inc
    • 14.2.2. Merck & Company Inc.
    • 14.2.3. Boehringer Ingelheim GmbH
    • 14.2.4. Elanco Animal Health Inc.
    • 14.2.5. Vetoquinol SA
    • 14.2.6. Virbac SA
    • 14.2.7. Phibro Animal Health Corporation
    • 14.2.8. Ceva Sante Animale S.A
    • 14.2.9. Covetrus Inc.
    • 14.2.10. Biogenesis Bago SA
    • 14.2.11. Neogen Corporation Ltd.
    • 14.2.12. Dechra Pharmaceuticals PLC
    • 14.2.13. ImmuCell Corporation
    • 14.2.14. Krka, tovarna zdravil, d. d., Novo mesto
    • 14.2.15. ECO Animal Health Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 3: Global Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 4: Global Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 5: Global Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 6: Global Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 7: Global Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 8: Global Animal Pharmaceuticals Market, By Region, By Value, 2016-2026F
  • Figure 9: Global Animal Pharmaceuticals Market, Market Map, By Value, 2016-2026F
  • Figure 10: North America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 11: North America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 12: North America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 13: North America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 14: North America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 15: North America Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 16: North America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 17: North America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
  • Figure 18: United States Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 19: United States Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 20: United States Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 21: United States Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 22: United States Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 23: United States Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 24: United States Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 25: Canada Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Canada Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 27: Canada Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 28: Canada Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 29: Canada Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 30: Canada Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 31: Canada Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 32: Mexico Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 33: Mexico Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 34: Mexico Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 35: Mexico Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 36: Mexico Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 37: Mexico Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 38: Mexico Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 39: Europe Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 40: Europe Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 41: Europe Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 42: Europe Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 43: Europe Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 44: Europe Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 45: Europe Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 46: Europe Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
  • Figure 47: Germany Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 48: Germany Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 49: Germany Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 50: Germany Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 51: Germany Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 52: Germany Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 53: Germany Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 54: United Kingdom Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 55: United Kingdom Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 56: United Kingdom Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 57: United Kingdom Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 58: United Kingdom Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 59: United Kingdom Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 60: United Kingdom Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 61: France Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: France Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 63: France Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 64: France Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 65: France Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 66: France Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 67: France Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 68: Italy Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 69: Italy Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 70: Italy Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 71: Italy Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 72: Italy Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 73: Italy Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 74: Italy Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 75: Spain Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 76: Spain Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 77: Spain Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 78: Spain Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 79: Spain Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 80: Spain Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 81: Spain Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 82: Asia-Pacific Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 83: Asia-Pacific Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 84: Asia-Pacific Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 85: Asia-Pacific Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 86: Asia-Pacific Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 87: Asia-Pacific Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 88: Asia-Pacific Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 89: Asia-Pacific Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
  • Figure 90: Australia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 91: Australia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 92: Australia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 93: Australia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 94: Australia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 95: Australia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 96: Australia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 97: Japan Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 98: Japan Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 99: Japan Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 100: Japan Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 101: Japan Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 102: Japan Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 103: Japan Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 104: China Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 105: China Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 106: China Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 107: China Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 108: China Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 109: China Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 110: China Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 111: India Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 112: India Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 113: India Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 114: India Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 115: India Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 116: India Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 117: India Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 118: South Korea Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 119: South Korea Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 120: South Korea Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 121: South Korea Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 122: South Korea Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 123: South Korea Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 124: South Korea Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 125: South America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 126: South America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 127: South America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 128: South America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 129: South America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 130: South America Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 131: South America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 132: South America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
  • Figure 133: Argentina Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 134: Argentina Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 135: Argentina Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 136: Argentina Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 137: Argentina Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 138: Argentina Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 139: Argentina Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 140: Brazil Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 141: Brazil Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 142: Brazil Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 143: Brazil Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 144: Brazil Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 145: Brazil Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 146: Brazil Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 147: Colombia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 148: Colombia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 149: Colombia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 150: Colombia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 151: Colombia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 152: Colombia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 153: Colombia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 154: Middle East and Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 155: Middle East and Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 156: Middle East and Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 157: Middle East and Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 158: Middle East and Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 159: Middle East and Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 160: Middle East and Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 161: Middle East and Africa Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
  • Figure 162: South Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 163: South Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 164: South Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 165: South Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 166: South Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 167: South Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 168: South Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 169: Saudi Arabia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 170: Saudi Arabia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 171: Saudi Arabia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 172: Saudi Arabia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 173: Saudi Arabia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 174: Saudi Arabia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 175: Saudi Arabia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 176: UAE Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
  • Figure 177: UAE Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
  • Figure 178: UAE Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
  • Figure 179: UAE Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
  • Figure 180: UAE Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
  • Figure 181: UAE Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
  • Figure 182: UAE Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F